Drugs / Allyl Isothiocyanate
Allyl Isothiocyanate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06809569 | Sep → Dec 2023 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allyl Isothiocyanate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06809569 ↗ |
| Known as | AITC | “Drug: Allyl Isothiocyanate (AITC)” NCT06809569 ↗ |
| Known as | Allyl isothiocyanate, stabilized | ChEMBL registry synonym — accepted as the source's own label CHEMBL233248 ↗ |
| Known as | FEMA NO. 2034 | ChEMBL registry synonym — accepted as the source's own label CHEMBL233248 ↗ |
| Known as | NSC-5572 | ChEMBL registry synonym — accepted as the source's own label CHEMBL233248 ↗ |
| Known as | Oil, mustard | ChEMBL registry synonym — accepted as the source's own label CHEMBL233248 ↗ |
| Modality | Small molecule | — CHEMBL233248 ↗ |
| Route | Other | “Topical administration” NCT06809569 ↗ |